SCHEMBL8470905

SCHEMBL8470905

CC(C)c1cccc2c1OCC(SC(=O)C(F)(F)F)C2=O

nearest known ligand 0.34

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.34
DPP4 P27487 2/20 0.32
ANPEP P15144 1/20 0.32
PTPN5 P54829 1/20 0.31
NR1H2 P55055 1/20 0.30
NR1H3 Q13133 1/20 0.30
GSTO1 P78417 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8470385 0.76 CYP19A1 (0.47) CYP19A1
SCHEMBL8470417 0.72 CYP19A1 (0.50) CYP19A1
SCHEMBL8473045 0.70 CYP19A1 (0.41) CYP19A1
SCHEMBL8472084 0.69 CYP19A1 (0.40) CYP19A1
SCHEMBL8472750 0.69 CYP19A1 (0.53) CYP19A1
SCHEMBL5598833 0.63 DPP4 (0.40) DPP4ANPEPNR1H2NR1H3
SCHEMBL7378114 0.63 ALDH1A1 (0.42)
SCHEMBL11494652 0.63 LMNA (0.43)
SCHEMBL4486201 0.62 MAOB (0.36) DPP4ANPEPNR1H2NR1H3
SCHEMBL8470906 0.61 DPP4 (0.33) DPP4ANPEPPTPN5NR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5886016-A ANTIINFLAMMATORY AGENT WITH MINIMAL SIDE EFFECTS FOR TREATING ARTHRITIS G.D. SEARLE & CO. (US) 1999-03-23 US disclosed
US-5670532-A Pyrazolyl derivatives for the treatment of inflammation G. D. SEARLE & CO. (US) 1997-09-23 US disclosed
US-5565482-A ANTIINFLAMMATORY AGENTS, ANTIARTHRITIC AGENTS G.D. SEARLE & CO. (US) 1996-10-15 US disclosed
US-5547975-A ANTIARTHRIC AGENTS, ANALGESICS AND ANTIPYRETICS; INHIBITORS OF CYCLOOXYGENASE II; SIDE EFFECT REDUCTION G.D. SEARLE & CO. 1996-08-20 US disclosed
WO-1996009304-A1 BENZOPYRANOPYRAZOLYL DERIVATIVES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-03-28 WO disclosed